GI pharm Flashcards

(35 cards)

1
Q

GERD and PUD

A

H2 receptor antagonists
PPI
mucosal protectants
antacids
antiemetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

increase protective factors

A

antacids
sucralfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

decrease aggressive factors

A

H. pylori
target gastric acid secretion: H2 blockers and PPI (parietal cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

H. pylori tm

A

several abx and gastric acid I
combo therapy to minimize resistance (likes acidic env and most abx dont thrive well there)
need confirmed case before treating bc resistance
10-14 days, adherence not great bc v expensive and up to 12 pills/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cimetidine
famotidine

A

h2 receptor antagonists
moa: block h2 receptors in stomach, reduce gastric acid secretion 60-70%, increases stomach pH
PO, IV at least 1 hr apart from antacids, OTC
I: GERD, PUD, ulcer prophylaxis - asp pna, heartburn/dyspepsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

h2 receptor antagonists: SE

A

well tolerates, CNS effects in elderly, slight increased risk of pna in elderly
interactions: inhibit cyp450 (cimetidine, thats why famotidine is used 1st line)
can increase warfarin, phenytoin, theophylline bc cyp450 I (esp cimetidine)
give IV slowly to avoid bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PPIs

A

omeprazole
patopracole
esomeprazole
moa: bind PP, inhibit H/K ATPase enzyme system (proton pump), irreversibly inhibits secretions of HCl - primary driver for stomach acid secretion
more effective than H2RA
I: short term treatment of PUD and GERD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PPI SE

A

short = safe
long (years) = increased risk of pna, bone loss/hip fracture, stomach cancer, benefits outweigh risks for most
few interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mucosal protectant

A

sucralfate
sucrose base, aluminum hydroxide
moa: alters when exposed to gastric acid, sticky thick gel -> protective barrier
I: duodenal ulcers, gastric ulcers, chronic gastritis
PO - tablet or suspension, take before you eat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sucralfate: SE

A

no major
may cause C
decrease drug abs, PO take 2 hrs apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

antacids: SE

A

Al and Ca based = c
Mg based = d
Mg + Al = balanced
acid rebound
chelation, altered gastric abs of many drugs (separate by 2hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antacids

A

moa: neutralize acid by approximately 50%
I: PUD (heal), GERD (s), stress ulcers (prophyl), heartburn and indigestion (for some)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antiemetics

A

serotonin blockers
antihistamines
anticholinergics
dopamine antagonists
prokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ondanestron

A

serotonin blocker
moa: block serotonin receptors in chemoreceptor trigger zone in brain and in afferent vagal nerves in stomach and SI
PO or IV
I: n/v, esp in chemo/radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ondanestron: SE

A

common
mild HA, d, dizzy, c
serotonin S
be aware of other drugs that affect serotonin (SSRI, SNRI, TCA, MAOIs, buspirone, tramadol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

antihistamines

A

dimenhydrinate
meclizine
hydroxyzine
moa: block release of histamine H1 receptors in inner ear
I: treat dizzy and n -> antiemetics and antivertigo associated with motion sickness

17
Q

antihistamines: SE

A

sedation, drowsy, dizzy
anticholinergic effect!
FALL RISK - esp elderly
not given IV -> tissue necrosis, gangrene

18
Q

dopamine antagonists

A

prokinetic agent = metoclopramide
moa: block dopamine receptors, increase tone of lower ES (GERD), increase peristalsis in stomach and intestine (diabetic gastroparesis and post op)
I: n/v associated with chemo/radiation/opioids, GI motility issues, paralytic ileus

19
Q

dopamine antagonists: SE

A

sedation
severe: extrapyramidal symptoms, restlessness, neuroleptic malignant S

20
Q

extrapyramidal s

A

drug induced movement disorders
metoclopramide + antipsychotic meds
akathisia: may feel restless, tense, constant desire to move
acute dystonia: invol muscle contractions
parkinsonism -> rigid muscles in limbs
tardive dyskinesia -> late onset, progressive S, repetitive facial movements - tongue twisting, cheek puffing, chewing motions, lip smacking, grimacing
neuroleptic malignant S -> worst, life threatening, muscle rigid 1st, fever, drowsy, confusion -> seizure

21
Q

drug therapy for diarrhea

A

diphenoxylate with atropine
loperamide
moa: decrease intestinal peristalsis, reduce intestinal effluent
SE: drowsy and c
fall and driving precautions esp with other CNS depressants
anticholinergic effects of atropine
serious: cardiac arrest/arrythmias (brady)

22
Q

IBS meds

A

5 aminosalicylates
DMARDs
not great at treating

23
Q

5 aminosalicylates

A

sulfasalazine
I: mild - mod IBS
moa: sulfonamide abx that converts intestine into 5 aminosalicyclic acid AND sulphapyridine
sulphapyridine has no therapeutic effect for IBD because of its SE some pt prefer mesalamine alone

24
Q

sulfasalazine: SE

A

n, fever, rash, HA, hematologic disorders
dont give to pt with sulfa allergy or who have certain types of anemias, caution for use in pt with many diseases - can cause lots of issues

25
DMARDs
infliximab disease modifying antirheumatic drug moa: monoclonal antibody that neutralizes TNF alpha (inflam mediator) I: lots, IBD
26
infliximab: SE
immune suppression: infection, cancer, HF, infusion rxn, neutropenia often require therapeutic drug monitoring and biomarker monitoring for inflam (CRP) screened for TB and other diseases before start, titers drawn, need vax
27
general tm
diet mod, sx, pharm
28
bismuth subsalicylate
adsorbent Coats walls of GI tract, bind causative agent for elimination (adsorption) I: diarrhea SE: Increased bleeding time, constipation, dark stools and tongue darkening Same as aspirin nc: Form of aspirin Activated charcoal also given in drug overdose
29
Loperamide (otc, slowed peristalsis only, no SE) Diphenoxylate (with anticholinergic, Rx)
antimotility moa: Slow peristalsis by reducing rhythmic contractions and smooth muscle tone of GI tract, drying effect due to anticholinergic – reduce gastric secretions I: d SE: Due to anticholinergic: Urinary retention, headache, dizziness, anxiety, drowsiness, bradycardia, hypotension, dry skin, flushing nc: Used alone or in combo with adsorbents and opiates
30
Lactobacillius organisms (Bacid, Culturelle) Saccharomyces boulardii (C. diff)
probiotics moa: replenish bacteria and restore normal flora I: d r/t abx, S. b is for C. diff nc: these bacteria make up majority of normal flora of gut, OTC or Rx strength
31
Docusate sodium Mineral oil
Emollient moa: Both prevent water from moving out of intestines DS - Lubricate fecal material and walls, promote fat absorption into fecal mass (soften stool) MO - lubricate intestines I: DS- Prevent opioid induced constipation MI - fecal impaction SE: Skin rashes, decreased absorption of vitamins NC: DS - given prophylactically for post op MI - PO and PR (rectal) or enema
31
psyllium
Bulk forming laxatives moa: Act similar to dietary fiber, absorb water into intestine – increasing bulk (volume), distend bowel to initiate flex bowel activity and bowel movement I: Okay for long term use Contraindicated for intestinal obstruction or fecal impaction SE: Impaction above strictures, fluid/electrolyte (less than other types of laxatives) imbalance, gas formation, esophageal blockage nc: Action limited to GI tract – no systemic affects Take with lots of water to prevent esophageal obstruction or fecal impaction (should be in 8-12 oz of water)
32
Glycerin Lactulose Polyethylene glycol
hyperosmotic moa: Increase water content in feces; promote distension, peristalsis, and evacuation L: works in colon; reduce blood ammonia levels I: G - common in children – suppository L - reduce blood ammonia levels – use with liver disease and hepatic encephalopathy PG - before diagnostic or surgical bowel procedures – total cleansing of bowel, very potent SE: Abdominal bleeding, rectal irritation, electrolyte imbalance
33
Magnesium salts (Mg citrate, Mg hydroxide, Mg sulfate) Sodium salts
Saline moa: Increase osmotic pressure and draw water into colon I: Constipation SE: Magnesium toxicity (in renal pts), electrolyte imbalance, cramping, diarrhea nc: Work within 3-6 hrs Mg salts available OTC Na salts usually given via fleet enema
34
bisacodyle senna
I: Constipation or whole bowel evacuation – work on entire GI tract SE: Nutrient malabsorption, gastric irritation, e imbalance NC: B - PO and PR OTC